SUMMARY. Serum total antioxidant activity (TAA), albumin and uric acid were measured on admission, and for the next 2 days in 56 patients suffering myocardial infarction, 20 of whom received streptokinase. The 'antioxidant gap', the difference between the serum T AA and the sum of the serum albumin and uric acid activity, was calculated. No significant changes in serum total antioxidant activity were observed in either group of patients between admission, day I and day 2. However, a decline in the 'antioxidant gap' after myocardial infarction was associated with a significantly higher mortality.
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There is now strong epidemiological evidence to suggest that increased intake of antioxidant nutrients decreases the risk of coronary heart diseasel ? or decreases the risk of recurring cardiac events." Plasma antioxidants show a negative association with age-standardized mortality from coronary vascular disease.! It is also possible that extracellular antioxidants may influence the outcome of coronary occlusive episodes, due to their availability to scavenge reactive oxygen species generated during the reperfusion phase. Some workers have found a rise in serum malondialdehyde after acute myocardial infarction.P-? while others have reported a fall in the serum total free radical trapping ability (TRAP).~Free radical generation and lipid peroxidation have also been demonstrated during coronary angioplasty"!? and unstable angina. I I A fall in the activity of serum antioxidants might also develop as a result of the sudden readmission of oxygen-rich blood into the heart after the removal of a coronary blockage.'? If occlusionjreperfusion causes significant consumption of antioxidants post myocardial infarction, then a greater fall might be expected in Correspondence: Dr NJ Miller, Free Radical Research Group, Division of Biochemistry and Molecular Biology, UMDS, Guy's Hospital, St Thomas's Street, London SEI 9RT, UK patients treated with thrombolytic therapy. Measurement of plasma thiobarbituric acidreactive substances (TBARS) during thrombolytic therapy suggested there was increased lipid peroxidative activity. However, this method is a non-specific marker of oxidative damage. Measurement of antioxidants over a longer time period might give more direct evidence of the severity of the oxidative stress during ischaemia and reperfusion. Other studies'v" have failed to show a statistically significant rise in free radical activity in the coronary venous blood on reperfusion after bypass surgery, suggesting that the source of the increase in TBARS might be tissues other than myocardium. Neutrophil activation, another potential source of free radical activity, has also been demonstrated I h after streptokinase therapy."
In the ferrylmyoglobin-ABTS assay for total antioxidant activity, the ABTS radical monocation (ABTSo+), a long-lived chromophore with absorption maxima at 417,645,734 and 815nm, is generated from the peroxidatic activity of metmyoglobin during its interaction with the phenothiazine compound 2,2' -azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and hydrogen peroxide.!? The presence of antioxidants in the reaction mixture will prevent an absorbance change by scavenging ABTSo+ as it is formed. The degree of inhibition of radical formation (as judged by the absorbance at 734 nm) can be related to the antioxidant activity of the added sample. The assay is calibrated with the water-soluble ex-tocopherol analogue Trolox (®Hoffman-La Roche).
In this study patients admitted through casualty were monitored to determine whether myocardial infarction produced a measurable fall in the serum antioxidant activity and whether such a decline was influenced by antithrombolytic therapy. and day + 2-the next day (35-54 h after myocardial infarction). Serum was separated and stored at -70°C for subsequent analysis. Five patients were excluded from further study because a myocardial infarction could not be positively confirmed. Fifty-six patients (37 men) mean age 66 (range 34-87) years, had a clinically confirmed infarction supported by electrocardiographic data together with a change in log total creatine kinase (CK) activity exceeding 0·015/h (based on two or more samples taken within 12 h of admission). \8 Twelve patients had a history of angina prior to infarction, II were hypertensive, five had experienced a previous myocardial infarction and one was diabetic. One patient also had a cerebral infarction and another suffered myocardial infarction after angioplasty. Thirty-seven patients (23 men) were selected for supportive therapy (analgesics and bed rest) on clinical grounds (such as cardiopulmonary resuscitation or peptic ulcer), while 19 patients (three women) were treated with thrombolytic therapy (streptokinase).
MATERIALS AND METHODS

Patients
The ferrylmyoglobinlABTS total antioxidant assay Three microlitres of sample was added to 355 ilL of solution containing ABTS (150 IlmoljL) and metmyoglobin (2,5 Ilmol/L). The reaction was started by the addition of hydrogen peroxide (75 Ilmol/L). After 6 min the absorbance of the solution at 734 nm was read on a Cobas Bio Ann cu« Biochem 1997: 34 centrifugal analyser, together with a buffer blank (which will have a higher absorbance than a solution containing plasma or antioxidants). The blank minus the test absorbance, divided by the blank absorbance, expressed the percentage inhibition of the reaction and was proportional to the antioxidant activity of the added sample.
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The assay was calibrated against an extocopherol analogue Trolox (Hoffman-La Roche) and results were expressed as millimoles per litre of Trolox activity. Inclusion of a low and high serum pool in each assay gave interassay coefficients of variation 6·1% and 3,6%, respectively. Readings were made at 734nm to overcome spectral interference from myoglobin and other haem proteins, whose absorptivity decreases greatly above 580 nm. Similarly, direct interference from bilirubin was minimized at this wavelength, as were the effects of lipaemia and sample turbidity. TAA values are unaffected by physiological doses of aspirin and by ingestion of drugs, such as {J-blockers, which are not free radical scavengers. Analysis of specimens taken simultaneously from a single subject showed that delays in centrifugation of up to 6 h did not significantly affect the TAA results obtained. Serum TAA was found to be stable for I week at 4°C and 6 months at -70°C. The reference interval for serum TAA by this method is I· 32-1·60 mmol/L,"?
Other laboratory methods Specimens were also analysed for albumin (by the bromocresol purple method) and uric acid (by the uricasejperoxidase/4-aminophenizone method) using reagents from Randox laboratories (Ardmore, Crumlin, Northern Ireland, UK). Values for serum albumin were expressed in mrnol/L taking Mr as 65000. 19 Total CK was measured by the hexokinasejglucose-6-phosphate dehydrogenase method and CK MB isoenzyme by the immunoinhibition method using a Dupont Dimension clinical chemistry analyser.
The antioxidant gap The 'antioxidant gap' was derived by subtracting the TAA activity ascribable to albumin and uric 
Statistics
The Mann-Whitney U-test was used to assess the significance of differences between results on different days, accepting P values of < 0·05 as significant. Association between groups of data were assessed using the Kendall rank-order correlation coefficient and comparison of the death rate between groups of patients was carried out by means of the "I: test. Tables I  and 2 . Compared with day 0, no significant changes for each analyte were observed following myocardial infarction, or between the two groups of patients (group I-thrombolytic therapy versus group 2---eonservative therapy). However, 12 of the patients treated with streptokinase and IS of the patients treated conservatively had TSAA values below the reference range of: I· 32 mmol(L during the study period. One patient in group 2 had an initial TSAA value that was above the upper limit of the reference interval.
RESULTS
A summary of the results are shown in
Comparing those patients whose antioxidant gap had fallen post myocardial infarction (n = 20) and those whose antioxidant gap had risen (n = 36), it was noted that five patients (25% of the group) whose antioxidant gap had fallen were dead 4 months after their infarction (each from a further myocardial infarction, one complicated by renal failure), while only one patient (2'8%) from the group whose antioxidant gap had risen died during the same period (also from a myocardial infarction), (x. 2 statistic = 6'64, P = 0·0 1). There was no significant difference between the antioxidant gap values for these two groups on day O. Six patients from group 1 (thrombolytic therapy) and 14 patients from group 2 (conservative therapy) experienced a fall in the antioxidant gap, while 13 patients in group 1 and 23 patients in group 2 showed a rise in the antioxidant gap immediately after myocardial infarction. No significant correlation was observed between the extent of the fall in antioxidant gap and the size of the infarct (as judged bỹ IOgIOCK) or with the CKMB or rate of change of the CKMB (data not shown). 18 
Serum antioxidant values after myocardial infarction in patients treated with thrombolytic therapy (group I). Median (range) of results shown
DISCUSSION
The role of albumin as a serum free radical scavenger is well established.P Albumin is the main source of thiol groups in the serum and protein thiol oxidation has been shown to be a sensitive and specific indicator of oxidant stress to the vascular compartment." Increased loss of albumin into the urine is known to be an early response to myocardial infarction.v-" Uric acid is the next most abundant serum antioxidant in terms of mass and activity.i" Ascorbic acid accounts for just under 10% of the total plasma antioxidant activity and its high hepatic and renal clearance make it unlikely that this value could be greatly raised. The remaining antioxidant activity in the plasma, up to 40% of the total activitY,17,25,26 is accounted for by substances such as IX-tocopherol, p-carotene, bilirubin, cysteine, glutathione, dihydrolipoate, ubiquinol and other phenolic and polyphenolic-? plasma components. The serum 'antioxidant gap' reflects the antioxidant activity of ascorbate, IX-tocopherol, carotene, bilirubin and radical-scavenging antioxidants other than albumin and uric acid. The results presented here suggest that serum antioxidant activity after myocardial infarction may be prognostic.
Very large oral doses of IX-tocopherol have been shown to reduce the size of experimental myocardial infarction in an animal model." However, other workers have suggested that serum levels of c-tocopherol are not associated with myocardial infarction risk in a human population with a high IX-tocopherol intake.i? It has also been suggested that low levels of carotenoids may be associated with an increased risk of subsequent myocardial infarction among smokers.P An earlier study of 31 patients sampled 6-12 h after myocardial infarction showed a significant fall in leucocyte ascorbic acid levels, occurring when the white cell count was at its maximum.'! Young et al. 32 have more recently demonstrated an early decrease in Ann Clin Biochem 1997: 34 plasma IX-tocopherol after myocardial infarction, followed by a fall in plasma ascorbate more than 24 h later. Given the emergency nature of myocardial infarction, it is difficult to collect timed blood samples and process them rapidly for analysis of ascorbic acid, a-tocopherol, carotenoids and other non-routine analytes; however further studies on the prognostic significance of changes in circulating antioxidants after myocardial infarction are clearly justified.
Studies in premature babies,17,33 smokers-" and asthmatics," all conditions of oxidative stress, have shown changes in serum total antioxidant activity. The results reported here show no statistically significant change in the TAA or antioxidant gap during the 48 h postmyocardial infarction for all patients, or when patients are grouped according to therapeutic category. An explanation for this may lie in the variable nature of myocardial infarction itself; for example, the position of the infarct, the condition of the remainder of the cardiac musculature and the duration and extent of pre-disposing disease. While there were striking changes in the TAA of some patients, there was little change in others. However, the antioxidant gap value declined in 29 of the 56 patients monitored, independent of the treatment given, which was reflected in a concomitant decline in the TAA. This fall suggests that changes in the 'gap' antioxidants are of significance in the events following myocardial infarction; it is proposed that this decline reflects the inappropriate neutrophil activation that may participate in the exacerbation of myocardial injury, and for which vitamin C and a-tocopherol supplementation has been recommended."
Mullholland and Strain," using the oxygen electrode method of Wayner et al. 26 measured the plasma total radical trapping antioxidant parameter (TRAP) in 15 patients after acute myocardial infarction and concluded that measured TRAP values were significantly lower (about 20%) in patients post myocardial infarction than in matched controls. However, these workers did not exclude the possibility that the patients studied had a lower TRAP value than controls prior to infarction, which might be expected if antioxidant deficiency is a predisposing factor to coronary vascular disease. The TAA and antioxidant gap of patients in this study treated with thrombolytic therapy (streptokinase) showed the same pattern of response as those treated with supportive therapy (i.e. aspirin, bed rest). Thus, while a localized increase in reactive oxygen species may arise after myocardial infarction as a consequence of the ischaemic event and the subsequent restoration of blood flow, this may not be reflected in the total antioxidant activity of the peripheral blood, which is in most cases primarily a reflection of the antioxidant activity of circulating albumin and uric acid.
